Cambridge Open Engage home
What is Cambridge Open Engage?
How to Submit
Browse
About
News [opens in a new tab]

Concise syntheses of GB22, GB13 and himgaline by cross-coupling and complete reduction

27 December 2021, Version 1
Working Paper
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Class III neuroactive metabolites from the bark of Galbu-limima belgraveana occur in variable distribution and are not easily procured by chemical synthesis. Here we decrease the synthetic burden of himgaline to nearly one-third of the prior best (7–9 vs. 19–31 steps) by cross-coupling high fraction aromatic (FAr) building blocks followed by com-plete, stereoselective reduction to high-fraction sp3 (Fsp3) products. This short entry into GB alkaloid space allows its extensive exploration and biological interrogation.

Keywords

Galbulimima
alkaloid
total synthesis
attached-rings
chemical space
natural products

Supplementary materials

Title
Description
Actions
Title
Supporting Information for Concise syntheses of GB22, GB13 and himgaline by cross-coupling and complete reduction
Description
Experimental procedures, copies of NMR spectra, X-ray structure reports, full outlines of prior syntheses, and Matplotlib Python code.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.

Version History

Dec 27, 2021 Version 1

Metrics

2,112
1,862
0
Views
Downloads
Citations

License

CC logo
CC
BY logo
BY
NC logo
NC
ND logo
ND
The content is available under CC BY NC ND 4.0 [opens in a new tab]

DOI

10.26434/chemrxiv-2021-8nlfl
D O I: 10.26434/chemrxiv-2021-8nlfl [opens in a new tab]

Funding

National Institutes of Health
GM122606
National Science Foundation
CHE1856747
Skaggs Graduate School
Bristol Myers Squibb
Jiangsu Industrial Technology Research Institute
Shionogi & Co., Ltd.
Japan Society for the Promotion of Science
17J08551

Author’s competing interest statement

A provisional patent has been filed

Ethics

The author(s) declare that they have sought and gained approval from the relevant ethics committee/IRB for this research and its publication.

Share